Floatz logo

[18F]FPyQCP

Invasive Lobular Breast Carcinoma

Blue Earth DiagnosticsPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Invasive Lobular Breast Carcinoma cohort.

Asset / SponsorPhaseRating
FULVESTRANT
M.D. Anderson Cancer Center
Phase 3BB
Arimidex
Alliance for Clinical Trials in Oncology
Phase 3B
FES F-18
Asan Medical Center
Phase 2B
FAPI74
Randy Yeh
Phase 2CCC
FLUDEOXYGLUCOSE
Randy Yeh
Phase 2CCC

View all 21 →

Same molecule, other indications

[18F]FPyQCP is also rated in:

ovarian carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
gastric cancerDormant
CC
Indicative ·
41 / 100
View asset →
pancreatic ductal adenocarcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →